This inventor holds 1 USPTO granted patent. Top assignee: Biochemie Gesellschaft M.b.h. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Kurt Schörgendorfer: Innovator in Nucleic Acid Technology
Introduction
Kurt Schörgendorfer is a notable inventor based in Langkampfen, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of nucleic acid molecules.
Latest Patents
Kurt Schörgendorfer holds a patent for a nucleic acid molecule encoding a cephalosporin acetylesterase. This invention relates to a nucleic acid molecule that codes for the cephalosporin acetylesterase from ATCC 6633 (DSM 11909). The patent also includes vectors and host cells that comprise such a nucleic acid molecule, a process for the recombinant preparation of cephalosporin acetylesterase from ATCC 6633 (DSM 11909) using the nucleic acid molecule, and a process for preparing 3-deacetylcephalosporin compounds. He has 1 patent to his name.
Career Highlights
Kurt Schörgendorfer is associated with Biochemie Gesellschaft M.b.h., where he applies his expertise in biotechnology. His work has contributed to advancements in the understanding and application of cephalosporin acetylesterase.
Collaborations
Kurt has collaborated with notable colleagues such as Franz Knauseder and Martin Schiestl, enhancing the research and development efforts within his field.
Conclusion
Kurt Schörgendorfer is a distinguished inventor whose work in nucleic acid technology has made a significant impact in biotechnology. His contributions continue to influence the development of innovative solutions in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile